FDA
-
-
-
-
-
-
-
Teva Pharma (TEVA) Announces US Approval of a Generic Version of Forteo
-
-
-
-
-
-
-
UZEDY™ (risperidone) Extended-Release Injectable Suspension Significantly Prolongs Time to Schizophrenia Relapse in RISE Study Results Published in The Lancet Psychiatry
-
-
-
-
-
-
-
Teva (TEVA) and Alvotech (ALVO) Provide Update on Partnership
-
-
-
-
-
-
-
Teva Pharma (TEVA) Announces AUSTEDO XR Now Available in the U.S.
-
-
-
-
-
-
-
Teva Pharma (TEVA), Alvotech (ALVO) fall following CRL for generic Humira
-
-
-
-
-
-
-
Immuneering Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Update on U.S. Regulatory Status of AVT02, Alvotech’s Proposed High-Concentration, Interchangeable Biosimilar to Humira®
-
249,557 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All